We are live on ! Find out more
RJA

Robshaw & Julian Associates Portfolio holdings

AUM $140M
1-Year Est. Return 13.69%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+13.69%
3 Year Est. Return
+19.35%
5 Year Est. Return
10 Year Est. Return
AUM
$130M
AUM Growth
+$8.8M
Cap. Flow
+$8.26M
Cap. Flow %
6.37%
Top 10 Hldgs %
42%
Holding
43
New
3
Increased
27
Reduced
5
Closed
4

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.37M
2
GLD icon
SPDR Gold Trust
GLD
+$1.12M
3
NUE icon
Nucor
NUE
+$770K
4
PG icon
Procter & Gamble
PG
+$523K
5
RTX icon
RTX Corp
RTX
+$260K

Sector Composition

Rank Sector Weight
1 Technology 17.01%
2 Energy 13.3%
3 Healthcare 12.79%
4 Financials 10.98%
5 Industrials 10.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBM icon
1
IBM
IBM
$214B
$7.61M 5.87%
41,364
+444
+1% +$78.2K
CVX icon
2
Chevron
CVX
$374B
$6.43M 4.96%
54,106
+2,555
+5% +$297K
AAPL icon
3
Apple
AAPL
$4.99T
$5.7M 4.39%
297,192
+8,680
+3% +$165K
JNJ icon
4
Johnson & Johnson
JNJ
$643B
$5.32M 4.1%
54,175
+3,325
+7% +$308K
JPM icon
5
JPMorgan Chase
JPM
$950B
$5.27M 4.06%
86,858
+12,078
+16% +$698K
AFL icon
6
Aflac
AFL
$65.9B
$5.12M 3.95%
162,400
+6,200
+4% +$197K
PFE icon
7
Pfizer
PFE
$144B
$4.98M 3.84%
163,456
+10,906
+7% +$325K
RTX icon
8
RTX Corp
RTX
$295B
$4.79M 3.69%
65,101
-3,615
-5% -$260K
VWO icon
9
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$4.73M 3.65%
116,555
-4,045
-3% -$157K
GE icon
10
GE Aerospace
GE
$377B
$4.54M 3.5%
36,561
+3,794
+12% +$469K
AMGN icon
11
Amgen
AMGN
$212B
$4.43M 3.41%
35,895
+625
+2% +$75.8K
INTC icon
12
Intel
INTC
$435B
$4.41M 3.4%
170,933
+5,165
+3% +$129K
SLB icon
13
SLB Ltd
SLB
$74.2B
$4.29M 3.31%
44,034
+2,550
+6% +$231K
DIS icon
14
Walt Disney
DIS
$172B
$4.25M 3.27%
53,055
+4,720
+10% +$366K
VGK icon
15
Vanguard FTSE Europe ETF
VGK
$30.2B
$4.08M 3.15%
+69,300
New +$4.05M
PEP icon
16
PepsiCo
PEP
$195B
$4.07M 3.13%
48,683
+1,790
+4% +$145K
NFG icon
17
National Fuel Gas
NFG
$7.73B
$3.96M 3.06%
56,614
+4,975
+10% +$364K
V icon
18
Visa
V
$697B
$3.85M 2.97%
71,388
+1,760
+3% +$97.8K
CSX icon
19
CSX Corp
CSX
$94.2B
$3.71M 2.86%
384,000
+31,650
+9% +$294K
GMF icon
20
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$417M
$3.69M 2.84%
25,875
-325
-1% -$24.3K
MKC icon
21
McCormick & Company Non-Voting
MKC
$13.9B
$3.19M 2.46%
88,908
+11,730
+15% +$395K
CAG icon
22
Conagra Brands
CAG
$7.38B
$2.67M 2.06%
110,594
+13,205
+14% +$317K
SU icon
23
Suncor Energy
SU
$75.4B
$2.56M 1.97%
73,239
+150
+0.2% +$5K
TPR icon
24
Tapestry
TPR
$30.5B
$2.35M 1.81%
47,270
+4,775
+11% +$238K
CSCO icon
25
Cisco
CSCO
$456B
$2.24M 1.73%
99,838
+4,475
+5% +$98.9K

Similar funds

Robshaw & Julian Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Robshaw & Julian Associates held 43 positions worth $130M, up 7.3% from $121M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Robshaw & Julian Associates deployed $8.26M of net new capital in Q1 2014, opening 3 new positions and adding to 27 existing holdings. Its largest new stake was Vanguard FTSE Europe ETF: 69,300 shares worth $4.08M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was RTX Corp, an estimated $260K trimmed.

  • Robshaw & Julian Associates's largest Q1 2014 buy was Vanguard FTSE Europe ETF: 69,300 shares worth $4.08M.
  • Robshaw & Julian Associates added most to JPMorgan Chase in Q1 2014, an estimated $698K increase.
  • Robshaw & Julian Associates's biggest Q1 2014 reduction was RTX Corp, cutting an estimated $260K.
  • Robshaw & Julian Associates fully exited Teva Pharmaceuticals in Q1 2014, selling an estimated $2.37M.
  • Robshaw & Julian Associates's ten largest holdings make up 42% of its $130M portfolio in Q1 2014.
  • Robshaw & Julian Associates opened 3 new positions and closed 4 in Q1 2014.
  • Robshaw & Julian Associates's portfolio value rose 7.3% quarter-over-quarter to $130M.

Based on Robshaw & Julian Associates's 13F filing for Q1 2014, filed 5 May 2014.